Pathophysiology
Modifiable Risk Factor: Non-Modifiable Risk Factor:
Geographical area – tropical islands Environment
in the Immunocompromise
Pacific and Asia Mosquito (Aedes aegypti)
Aedes aegypti (dengue virus carrier): 8-
12 days of viral replication on
mosquito’s salivary glands.
Bite from mosquito (Portal of Entry in
the Skin) Redness & itchiness in the
area
Allowing dengue virus to be inoculated
towards the circulation/blood (Incubation
Period: 3-14 days)
Virus disseminated rapidly into the blood and
stimulates WBCs including B lymphocytes that Diagnostic:
produces and secretes immunoglobulins Hematology:
(antibodies), and monocytes/macrophges, Increased WBC:
neutrophils 12,900/cumm
(5,000- 10,000/cumm)
Increased Lymphocytes:
49% (20-40%)
Antibodies attach to the viral antigens, and
Diagnostic: then monocytes/macrophages will perform
Hematology: phagocytosis through Fc receptor (FcR) within
Decreased Monocytes: 4 the cells and dengue virus replicates in the
%( 8-14%) cells.
Decreased Neutrophils: 49 Entry to the Entry to the
%( 50-70%) spleen, and bone marrow
liver
Recognition of dengue viral antigen on
infected monocyte by cytotoxic T cells
Signs/ symptoms: Release of cytokines which consist of vasoactive
Febrile: 38.6C agents such as interleukins, tumor necrosis factor,
Severe headache (retro- urokinase and platelet activating factors which
ocular) stimulates WBCs and pyrogen release
Nausea and vomiting;
rash (maculopapular,
petechial, or
erythematous)
Itching
aberrations in the sense
of taste(metallic taste) Dengue Hemorrhagic Fever